📰 Given Marimed News
Page 2 - Given Marimed News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Marimed. Real-time updates on events, politics, business and more.
June 6, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 50 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare MariMed to similar companies based on the strength of its profitability, dividends, earnings, valuation, analyst recommendations, risk and institutional ownership. Profitability This table compares MariMed and its […]
June 2, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its rivals? We will compare MariMed to related companies based on the strength of its analyst recommendations, earnings, risk, institutional ownership, profitability, dividends and valuation. Profitability This table compares MariMed […]
June 2, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare MariMed to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, dividends and risk. Risk & Volatility MariMed has a beta […]
June 1, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 public companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare MariMed to similar companies based on the strength of its earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Risk & Volatility MariMed has a beta […]
May 29, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare MariMed to related businesses based on the strength of its profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Analyst Recommendations This is a breakdown of […]
May 28, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 public companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare MariMed to related companies based on the strength of its institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings. Analyst Recommendations This is a breakdown of […]
May 26, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare MariMed to related companies based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation. Institutional and Insider Ownership 0.3% of MariMed […]
May 26, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 public companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare MariMed to related companies based on the strength of its institutional ownership, earnings, valuation, analyst recommendations, profitability, dividends and risk. Profitability This table compares MariMed and its […]
May 23, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its competitors? We will compare MariMed to similar companies based on the strength of its earnings, analyst recommendations, profitability, dividends, valuation, institutional ownership and risk. Risk and Volatility MariMed has a beta […]
May 21, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare MariMed to related businesses based on the strength of its valuation, dividends, profitability, analyst recommendations, earnings, institutional ownership and risk. Risk and Volatility MariMed has a beta […]